Figure 4From: Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitisInfluence of corticosteroid treatment on serum apoA-I levels of patients with NMO. High-dose intravenous corticosteroid treatment was given to patients with NMO for one week.Back to article page